AstraZeneca receives $486M in U.S. funding to advance Covid-19 antibody treatment
October 12, 2020 at 11:24 AM EDT
The therapy is similar to the monoclonal antibody treatment by Regeneron that President Trump received.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|